Sarepta Therapeutics Comments on Erroneous Submission to US FDA Adverse Event Reporting System (FAERS)

Go back to Sarepta Therapeutics Comments on Erroneous Submission to US FDA Adverse Event Reporting System (FAERS)

Sarepta Therapeutics (SRPT) to Resume Trading at 3:45 pm

August 8, 2019 3:34 PM EDT

Sarepta Therapeutics (NASDAQ: SRPT) to Resume Trading at 3:45 pm

... More